Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
apple cider vinegar-Western University refers to an investigational agent consisting of Jamieson Apple Cider Vinegar with Chromium caplets (NPN: 80078433) being evaluated in an Early Phase 1 clinical trial by Western University. The study investigates the supplement's potential to mitigate metabolic complications, such as insulin resistance and bone density loss, in men with metastatic castration-sensitive prostate cancer (mCSPC) who are receiving androgen deprivation therapy (ADT). The active ingredient, acetic acid (acetate), is hypothesized to act as a prebiotic that increases the abundance of the beneficial gut bacterium Akkermansia muciniphila. This shift in the gut microbiome is intended to improve metabolic health and bone integrity, counteracting the side effects of hormonal therapy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on apple cider vinegar-Western University.